Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Conduit Pharmaceuticals Inc CDT

Technology Scientific & Technical Instruments
Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company’s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CDT)

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

GlobeNewswire 2 days ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

GlobeNewswire 3 days ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

GlobeNewswire November 4, 2024

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

GlobeNewswire November 1, 2024

Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire August 28, 2024

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

GlobeNewswire August 12, 2024

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

GlobeNewswire August 8, 2024

Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

GlobeNewswire July 16, 2024

Conduit Pharmaceuticals to Join Russell 3000® Index

GlobeNewswire June 13, 2024
View More News ››

Opinion & Analysis (NDAQ:CDT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CDT)

Conduit Pharmaceuticals Announces Appointment of Simon Fry t

NEWS: $CDT Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of DirectorsConduit Pharmaceuticals strengthens its Board...
whytestocks - 3 days ago

Using dollar cost averaging for this stock.

My actual cost of this one now is .2120 cents per share and good luck to all of us shareholders.Big holder of this one and hoping for an...
coolfooldumbguy - October 23, 2024

RE:This stock is still cheap.

Doubled down on my holdings of this one this morning.It was my reason to use Dollar Cost Averaging by buying a big amount of shares...
coolfooldumbguy - October 23, 2024

This stock is still cheap.

Got in this morning,bought 50000 shares at .3029 per share and it is a hold until the year end,so do your own research & good luck to...
coolfooldumbguy - July 16, 2024
View more Bullboard ››

G Mining Ventures Corp.

G Mining Ventures Corp.

G Mining Ventures Corp. is a Canada-based intermediate gold producer. The Company is engaged in the acquisition, exploration ...
View More »